News
July 26, 2012 — Cambridge Heart Inc., a developer of non-invasive diagnostic tests for cardiac disease, announced that results of a prospective, 155-patient trial reinforces the value of the Microvolt T-Wave Alternans (MTWA) test as a predictor of life-threatening heart rhythms and sudden cardiac death (SCD). The results were published this week in the journal Kardiologia Polska.
July 26, 2012
Technology
July 26, 2012 — Transgenomic Inc. has announced that National Government Services, the designated Medicare fiscal intermediary in Connecticut, has confirmed coverage for its proprietary Clopidogrel Genetic Absorption Activation Panel (C-GAAP, formerly PGxPREDICT: Clopidogrel).
July 26, 2012News
July 26, 2012 — Angion Biomedica Corp. announced that the first patient was dosed in a Phase II multicenter clinical trial evaluating BB3 for the treatment of heart attack (acute myocardial infarction). The first patient, a 69-year-old man, was treated at Yale-New Haven Hospital in Connecticut. This double-blind, placebo-controlled study is designed to enroll 80 patients following a first heart attack.
July 26, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds from the redevelopment commission of the city of Gary, Ind., toward the development of Positron's 70 MeV cyclotron project.
July 25, 2012News
July 25, 2012 — Grady Memorial Hospital has standardized and improved patient education and reduced by 75 percent the amount of time staff spend educating new patients about warfarin by implementing Emmi Solutions’ interactive multimedia program in its Coumadin clinic.
July 25, 2012
Feature
Corindus Vascular Robotics today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the CorPath 200 robotic-assist system for use in percutaneous coronary interventions (PCI).
July 25, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Brian Duncan, St. Mary’s Healthcare System
St. Mary’s Healthcare System is a 199-bed hospital in Athens, Ga., and has been a trusted presence in the community since 1938. Our radiology picture archiving and communication system (PACS) was installed about nine years ago and on average, we perform 100,000 radiology studies a year. That system has served the radiology department at St. Mary’s very well.
July 24, 2012
Videos | Vena Cava Filters
This video, provided by Crux Biomedical, demonstrates the implantation of the FDA-cleared Crux VCF inferior vena cava ...
July 24, 2012News
July 24, 2012 — Use of the retrograde approach to revascularizing coronary chronic total occlusions (CTOs) to deliver catheters to the back end of the plug, rather than attacking it head-on, can be far more successful. This was according to research presented during the recent Society of Cardiovascular Angiographic Interventions (SCAI) 2012 Scientific Sessions.
July 24, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023Technology
July 24, 2012 — The importance of utilizing computed tomography (CT) in pre-planning for transcatheter aortic valve implementation (TAVI) and the benefits from viewing CT images via the Philips IntelliSpace Portal was highlighted at the 7th Annual Society of Cardiovascular Computed Tomography (SCCT) Scientific Meeting, July 19-22 in Baltimore, Md.
July 24, 2012
Technology
July 24, 2012 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its new cardiac imaging platform, the Discovery CT750 HD FREEdom Edition.
July 24, 2012
News
July 23, 2012 — Biotronik announced that the first CRT-D patient has been enrolled in the Biotronik EuroEco Trial — the European Health Economic Trial on Home Monitoring in implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy device (CRT-D) patients. The aim of the study is to assess the economic effects of Biotronik Home Monitoring-based remote follow-up management compared to conventional in-clinic or practice follow-ups.
July 23, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
July 23, 2012 — The IT and medical technology company Sectra has acquired the product rights for Intulo, a system that monitors radiation doses, from the Swedish medical IT company Krucom AB. The system enables major time and quality gains in medical care and reduces the risk of patients being exposed to unnecessarily high radiation doses in conjunction with radiology examinations.
July 23, 2012
Technology
July 23, 2012 — Siemens Healthcare expands its ultrasound portfolio with the portable Acuson P300 ultrasound system designed for a wide variety of clinical settings. Integrating high-performance hardware and software, the Acuson P300 system offers 13 multifrequency transducers for high clinical versatility. The system also features advanced image optimization technologies to support both routine and specialty application needs.
July 23, 2012
News
July 23, 2012 — Medtronic Inc. announced the first patient enrollment in a clinical trial comparing the CoreValve system with surgical aortic valve replacement in patients with severe aortic stenosis who are at intermediate risk to undergo open heart surgery. The Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial will evaluate the potential for the minimally invasive system to be considered for less-sick patients who typically are treated with open-heart surgical aortic valve replacement (SAVR) today.
July 23, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now